Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The endothelium in glomerular inflammation

T Takano1, H R Brady

  • 1Renal Section, Brockton-West Roxbury Veterans Administration Medical Center, Boston, Massachusetts, USA.

Current Opinion in Nephrology and Hypertension
|May 1, 1995
PubMed
Summary

Recent advances highlight adhesion molecules in endothelial activation, crucial for kidney diseases like glomerulonephritis. Understanding these interactions aids developing targeted therapies for renal inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential vascular roles for lipoxins in the "stop programs" of host defense and inflammation.

Trends in cardiovascular medicine·2011
Same author

Common polymorphisms of the PAI1 gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2007
Same author

Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2004
Same author

Posture-related tachycardia in older patients with hyponatremia.

Archives of gerontology and geriatrics·2004
Same author

Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases.

Cancer·2001
Same author

Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo.

Journal of immunology (Baltimore, Md. : 1950)·2001

Area of Science:

  • Nephrology and Immunology
  • Endothelial Biology
  • Molecular Medicine

Background:

  • Endothelial activation is a key factor in various kidney diseases, including glomerulonephritis, vasculitis, and transplant rejection.
  • Leukocyte trafficking to the glomerulus is mediated by specific adhesion molecules.
  • Inflammatory mediators and cytokines critically regulate leukocyte-endothelial cell interactions.

Purpose of the Study:

  • To summarize recent breakthroughs in endothelial biology relevant to glomerular inflammation.
  • To emphasize the role of selectin, mucin, integrin, and immunoglobulin-like adhesion molecules.
  • To highlight the potential for novel immunosuppressive strategies in renal diseases.

Main Methods:

  • Review of recent literature on endothelial cell activation and leukocyte trafficking.

Related Experiment Videos

  • Analysis of the role of specific adhesion molecules in inflammatory processes.
  • Identification of regulatory mechanisms involving inflammatory mediators and cytokines.
  • Main Results:

    • Major advances have elucidated the function of selectin, mucin, integrin, and immunoglobulin-like adhesion molecules in leukocyte trafficking.
    • Novel mechanisms regulating leukocyte-endothelial cell interactions have been defined.
    • These findings pave the way for new experimental immunosuppressive strategies.

    Conclusions:

    • Understanding endothelial activation and leukocyte trafficking is vital for treating glomerular inflammation.
    • Recent discoveries offer a foundation for developing targeted and potent therapies for renal diseases.
    • Further research into these molecular interactions promises significant clinical advancements.